Skip to main content Help Control Panel

Lost? Search this Naples Florida website...|Add our search|Login   A+   A-

Categories «   Keywords «  

Acute Allergic Reaction

Acute Allergic Reaction

JDP Successfully Completes Its Initial Phase 3 Clinical Trial of JDP-205 in Patients with Acute Urticaria Associated with an Acute Allergic Reaction -  JDP Therapeutics Inc., a privately held specialty pharmaceutical company, is pleased to announce that the Company has successfully completed the initial Phase 3 clinical trial (ETTAU-02) on its lead candidate JDP-205 in patients with acute urticaria associated with an acute allergic reaction. The result of this study has met and/or outperformed every parameter designed for this trial.  »
By GCL PRL, created on Jan. 9 2015
In Press Releases and Company Profiles